Cargando…
Tocilizumab in Large Vessel Vasculitis – Different Routes of Administration
BACKGROUND: Tocilizumab is increasingly used in the treatment of large vessel vasculitis with recent approval for giant cell arteritis. OBJECTIVE: To determine the efficacy and safety of tocilizumab in large vessel vasculitis in a real-life setting using different routes of administration. METHODS:...
Autores principales: | Schmalzing, Marc, Gadeholt, Ottar, Gernert, Michael, Tony, Hans-Peter, Schwaneck, Eva C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128017/ https://www.ncbi.nlm.nih.gov/pubmed/30258504 http://dx.doi.org/10.2174/1874312901812010152 |
Ejemplares similares
-
Autologous hematopoietic stem cell transplantation in systemic sclerosis induces long-lasting changes in B cell homeostasis toward an anti-inflammatory B cell cytokine pattern
por: Gernert, Michael, et al.
Publicado: (2019) -
Autologous Stem Cell Transplantation in Common Variable Immunodeficiency: A Case of Successful Treatment of Severe Refractory Autoimmune Encephalitis
por: Froehlich, Matthias, et al.
Publicado: (2020) -
Lymphocyte subsets in the peripheral blood are disturbed in systemic sclerosis patients and can be changed by immunosuppressive medication
por: Gernert, Michael, et al.
Publicado: (2021) -
Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy
por: Gernert, Michael, et al.
Publicado: (2022) -
Low B cell counts as risk factor for infectious complications in systemic sclerosis after autologous hematopoietic stem cell transplantation
por: Gernert, Michael, et al.
Publicado: (2020)